Nasdaq rallies to kick off the trading week📈

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. 

Here’s what moved the market today.

Markets 📈

The Nasdaq and Russell 2K rallied to start the trading week, while the Dow and S&P 500 edged higher by around half-a-point.

Sponsored

Hedge Funds are Devouring These Stocks 

Which stocks are major institutional investors, including hedge funds, buying now?

Find out with MarketBeat's list of 13 stocks Institutional investors are up as quickly as they can.

Get it FREE on the Next Page »

Market-Moving News 🔎 

📈 Tech Titans Driving the S&P 500 Surge!

Hello, record books! The S&P 500 has leaped to its peak for the first time since those heady days two years ago.

But here's the twist: it's mostly the info tech sector waving the flag at these record heights.

🤔 Macro Shift: 
Rewind two years, and the picture was a bit different. We had eight sectors basking in record glory, tech included.

Fast forward to now, and the tech heavyweights like Apple and Microsoft are the MVPs, shouldering the rally.

They're not alone, though, with Eli Lilly, Berkshire Hathaway, and Merck also strutting their high-value stuff, as per S&P Dow Jones Indices.

📊 Lean on the Big Guns: 
When just a few big kahunas dominate the gains, it's like putting too many eggs in one basket.

If these market giants trip, the whole index could feel the quake, so let’s hope the Magnificent 7 and other big names stay strong.

OneMedNet [ONMD] $1.37 (+168.2%)
announcing its participation at the 15th annual SCOPE Summit next month to discuss leveraging real-world data for clinical research.

Fibrogen [FGEN] $1.71 (+82.7%)
jumped after a SC 13G/A filing revealed BlackRock has built a 7.3% equivalent ownership stake in the company.

Neximmune [NEXI] $9.30 (+73.8%)
experienced a “circuit breaker” trading halt in today’s session, as shares skyrocketed despite no obvious catalyst.

Panbela Therapeutics [PBLA] $1.48 (65.3%)
price a $9 million public offering of its common stock & associated common warrants at $2.06 apiece.

Corbus Pharma [CRBP] $18.62 (-50.9%)
filed a Form 424B3 that revealed it has sold approximately $16.8 million worth of its common shares authorized under a previously announced sales agreement.

Semper Paratus SPAC [LGST] $5.55 (26.7%)
shareholders voted on the SPAC’s proposed business combination with Tevogen Bio today, but results of the vote couldn’t be obtained at the time we published this newsletter.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Text ELITESTOCKS to 47121 or click here to get our alerts on your mobile device, and never miss another fast-moving stock!

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.